A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.
Microbes that result in beach closures and health advisories when detected at unsafe levels in the ocean also have been detected in the sand, according to a recent study by a team of Stanford scientists.
A new study examined the relationship between physical appearance concerns and psychological distress (depression and anxiety) in patients with RA and lupus.
A new study sheds light on the brain pathways of depression in general and in central nervous system dysfunction in SLE in particular.
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic rhinitis and ocular allergies.
The Food and Drug Administration (FDA) announced the approval of Aptivus (tipranavir) capsules, an HIV protease inhibitor, to be given with ritonavir for treatment of HIV-1 infected adults. This is the second drug approved for patients with advanced HIV disease, and provides a new therapy for patients with limited treatment options.
Learn the Maharishi Ayurveda approach to menopause with author and clinician Nancy Lonsdorf M.D.. Dr. Lonsdorf describes how to determine the type of imbalances at the basis of menopausal symptoms and provides practical recommendations to help prevent and alleviate them.